What does Novartis Venture Fund/ JJDC invest in?
Novartis Venture Fund/ JJDC invests most often at Series A and Series B (100% of the rounds on record).
Last cheque observed Sep 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
2 rounds on record
Mostly Series A and Series B: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies Novartis Venture Fund/ JJDC put money into.
Novartis Venture Fund/ JJDC invests most often at Series A and Series B (100% of the rounds on record).
2 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2018.
Its most recent investments on record: 27-8 Therapeutics (Series A, Sept 2018) and Ribon Therapeutics (Series B, Jan 2018).
The median round it joins is $65M.
No investments in the last 12 months; the latest was in Sept 2018.
Novartis Venture Fund/ JJDC is a VC firm.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it